期刊文献+

大鼠发展至COPD过程中凝血纤溶指标变化 被引量:10

THE CHANGES OF COAGULATION AND FIBRINOLYTIC SYSTEM IN THE PROGRESS OF A RAT BECOMES CHRONIC OBSTRUCTIVE PULMONARY DISEASE
下载PDF
导出
摘要 目的观察大鼠发展至慢性阻塞性肺疾病(COPD)过程中各时期凝血、纤溶指标变化。方法将Wistar大鼠50只随机分为正常对照组和COPD造模1周组、2周组、3周组、4周组,每组10只。采用熏吸香烟加气管内注入脂多糖的方法建立COPD模型。观察各组肺组织病理改变,用BE-Compact全自动凝血分析仪测定血浆凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)和纤维蛋白原(FIB)、血浆抗凝血酶Ⅲ(AT-Ⅲ)水平,应用酶联免疫吸附法(ELISA)测定血浆组织型纤溶酶原激活物(t-PA)及其抑制物(PAI-1)和D-二聚体(D-dimer)水平。结果 4周组大鼠病理学改变符合人类COPD的特点,1~3周组大鼠肺组织病理分别符合急性支气管炎、慢性支气管炎、肺气肿期的病理改变。1周组大鼠PT、TT、ATⅢ、APTT、FIB、PAI-1t、PA、D-dimer水平较对照组无明显差异(P>0.05);2周组、3周组大鼠FIB、PAI-1、D-dimer水平较对照组升高,而ATⅢt、PA水平较对照组降低(F=8.52~18.90,q=3.46~6.55,P<0.05、0.01);4周组大鼠FIB、PAI-1、D-dimer水平较对照组升高,PT、APTT、ATⅢ、tPA水平较对照组降低(F=6.61~105.79,q=4.71~17.14,P<0.01)。结论 COPD大鼠存在血栓前状态,在大鼠形成COPD之前其体内的凝血纤溶系统处于失衡状态。 Objective To observe the changes of index of coagulation and fibrinolytic system in the progress of a rat to become chronic obstructive pulmonary disease(COPD). Methods Fifty Wistar rats were equally randomized to normal control,1-week-,2-week-,3-week-,and 4-week-COPD group.A model of COPD in rats was created by exposure in cigarette smoking and intratracheal instillation of lipopolysaccharide.The pathology of lung tissue in each group was observed;PT,FIB,TT,APTT and ATⅢ were determined by BE-Compact automated blood coagulation analyzer;The blood plasma levels of tPA,PAI-1 and D-dimer were measured by ELISA method. Results The 4-week group was consistent with the rat COPD model,its pathological changes were in line with the features of COPD in man.The pathology of lung tissues of rats in 1-week-to 3-week-group was consistent with acute bronchitis,chronic bronchitis and emphysema,respectively.In 1-week-COPD,PT,TT,ATⅢ,APTT,FIB,PAI-1,tPA,and D-dimer were not significantly different as compared with the control(P0.05);In 2-week-COPD and 3-week-COPD,the levels of FIB,PAI-1 and D-dimer were higher than that in the control(P0.05,0.01),while ATⅢ and tPA were lower(P0.01);In 4-week-COPD,the levels FIB,PAI-1 and D-dimer were higher than that in the control(P0.01),while PT,APTT,ATⅢ,and tPA were lower(P0.01). Conclusion Pre-thrombus state is existent in COPD rats.The coagulation and fibrinolytic system in rats are unbalanced before they are involved in COPD.
出处 《青岛大学医学院学报》 CAS 2011年第4期340-343,共4页 Acta Academiae Medicinae Qingdao Universitatis
关键词 肺疾病 慢性阻塞性 血液凝固 纤维蛋白溶解 大鼠 pulmonary disease chronic obstructive blood coagulation fibrinolysis rats
  • 相关文献

参考文献19

二级参考文献56

  • 1程兆忠,徐晟伟,韩伟忠.氨溴索对慢性阻塞性肺疾病大鼠模型肺的保护作用[J].青岛大学医学院学报,2004,40(2):101-103. 被引量:10
  • 2王慧,程德云,关键,陈小菊,张永.单核细胞趋化蛋白-1与COPD大鼠气道炎症的研究[J].四川大学学报(医学版),2004,35(5):634-637. 被引量:9
  • 3曾春芳,吴亚梅.细胞粘附分子在慢性阻塞性肺疾病大鼠气道炎症中的作用[J].重庆医科大学学报,2004,29(5):644-647. 被引量:3
  • 4高育瑶 张爱莉 等.全国肺部感染学术会议纪要[J].中华结核和呼吸杂志,1990,13(6):368-368.
  • 5中华医学会呼吸病学会.医院内获得性支气管-肺感染诊断标准[J].中华结核和呼吸杂志,1990,13:372-372.
  • 6Danl,Tybjaerg - Hansen A, Vestbo J, et al. Elevated plasma fibringgen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Grit Care Med,2001, 164(6) :1008.
  • 7Pauwels RA, Buist AS, Calverley PM, et al. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBL/WHO Global initiative for Chronic Obstructive Lung Disease(GOLD) Workshop summary[ J]. Am J Respir Crit Care Med, 163 : 1256 - 1276.
  • 8[3]Tiddens H, Silerman M, Bush A. The role of inflammation in airwaydisease.Remodelling[J]. Am J Cirt Med,2000,162:7.
  • 9[4]Zwablo KG ,Servais MD ,Schmutzler W ,et al .Ambroxol inhibits histamine release from human adenoidal mast cells[J]. Inflamm Res ,1998 ,47(Suppll) :S16.
  • 10[5]Gillissen A ,Nowak D .Characterization of N-acetylcysteine and ambroxol in antioxedant therapy[J].Respir Med, 1998,92 (4):609.

共引文献970

同被引文献103

引证文献10

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部